KENNETH A. THOMAS

Person

CHATHAM, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Systems and methods for angiogenic treatment in wound healing
- Patent number 12,168,038
- Issue date Dec 17, 2024
- Venturis Therapeutics, Inc.
- Vance Gardner
- G01 - MEASURING TESTING
Information Patent Grant
Therapeutic angiogenesis for treatment of the spine and other tissues
- Patent number 11,224,635
- Issue date Jan 18, 2022
- Venturis Thereuptics, Inc.
- Vance Gardner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified fibroblast growth factors for the treatment of ocular diso...
- Patent number 11,103,553
- Issue date Aug 31, 2021
- TREFOIL THERAPEUTICS, INC.
- David Eveleth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Angiogenic treatment of ischemic heart disease
- Patent number 10,966,610
- Issue date Apr 6, 2021
- Venturis Therapeutics, Inc.
- Vance Gardner
- G01 - MEASURING TESTING
Information Patent Grant
Systems and methods for angiogenic treatment in wound healing
- Patent number 10,624,952
- Issue date Apr 21, 2020
- CardioVascular BioTherapeutics, Inc.
- Vance Gardner
- G01 - MEASURING TESTING
Information Patent Grant
Therapeutic angiogenesis for treatment of the spine
- Patent number 8,983,570
- Issue date Mar 17, 2015
- CardioVascular BioTherapeutics, Inc.
- Thomas J. Stegmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,841,367
- Issue date Jan 11, 2005
- Merck & Co., Inc.
- Richard L. Kendall
- G01 - MEASURING TESTING
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,841,382
- Issue date Jan 11, 2005
- Merck & Co., Inc.
- Richard L. Kendall
- G01 - MEASURING TESTING
Information Patent Grant
Vascular endothelial cell growth factor C subunit
- Patent number 6,569,434
- Issue date May 27, 2003
- Merck & Co., Inc.
- Marvin L. Bayne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Angiogenesis inhibitors
- Patent number 6,380,203
- Issue date Apr 30, 2002
- Merck & Co., Inc.
- Mark T. Bilodeau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene therapy for inhibition of angiogenesis
- Patent number 6,375,929
- Issue date Apr 23, 2002
- Merck & Co., Inc.
- Kenneth A. Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,359,115
- Issue date Mar 19, 2002
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiogenesis inhibitors
- Patent number 6,235,741
- Issue date May 22, 2001
- Merck & Co., Inc.
- Mark T. Bilodeau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiogenesis inhibitors
- Patent number 6,228,871
- Issue date May 8, 2001
- Merck & Co., Inc.
- Mark E. Fraley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,204,011
- Issue date Mar 20, 2001
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vascular endothelial cell growth factor II
- Patent number 6,180,107
- Issue date Jan 30, 2001
- Merck & Co., Inc.
- Marvin L. Bayne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vascular endothelial cell growth factor C subunit
- Patent number 6,140,073
- Issue date Oct 31, 2000
- Merck & Co., Inc.
- Marvin L. Bayne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vascular endothelial cell growth factor C subunit
- Patent number 5,994,300
- Issue date Nov 30, 1999
- Merck & Co., Inc.
- Marvin L. Bayne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitor of vascular endothelial cell growth factor
- Patent number 5,861,484
- Issue date Jan 19, 1999
- Merck & Co., Inc.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vascular endothelial cell growth factor II
- Patent number 5,726,152
- Issue date Mar 10, 1998
- Merck & Co., Inc.
- Marvin L. Bayne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
DNA encoding a soluble VEGF inhibitor
- Patent number 5,712,380
- Issue date Jan 27, 1998
- Merck & Co., Inc.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purification and characterization of a glioma-derived growth factor...
- Patent number 5,532,343
- Issue date Jul 2, 1996
- Merck & Co., Inc.
- Marvin L. Bayne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cysteine-modified acidic fibroblast growth factor and methods of use
- Patent number 5,409,897
- Issue date Apr 25, 1995
- Merck & Co., Inc.
- Kenneth A. Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Brain derived and recombinant acidic fibroblast growth factor
- Patent number 5,401,832
- Issue date Mar 28, 1995
- Merck & Co., Inc.
- David L. Linemeyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding glioma-derived growth factor having vascular endotheli...
- Patent number 5,338,840
- Issue date Aug 16, 1994
- Merck & Co., Inc.
- Marvin L. Bayne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cysteine-modified acidic fibroblast growth factor
- Patent number 5,312,911
- Issue date May 17, 1994
- Merck & Co., Inc.
- Kenneth A. Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cysteine-modified acidic fibroblast growth factor
- Patent number 5,223,483
- Issue date Jun 29, 1993
- Merck & Co., Inc.
- Kenneth A. Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purification and characterization of a protein fibroblast growth fa...
- Patent number 4,444,760
- Issue date Apr 24, 1984
- Merck & Co., Inc.
- Kenneth A. Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Systems and Methods for Angiogenic Treatment in Wound Healing
- Publication number 20240415932
- Publication date Dec 19, 2024
- Venturis Therapeutics, Inc.
- Vance Gardner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISO...
- Publication number 20210338777
- Publication date Nov 4, 2021
- TREFOIL THERAPEUTICS, INC.
- David EVELETH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANGIOGENIC TREATMENT OF ISCHEMIC HEART DISEASE
- Publication number 20210212565
- Publication date Jul 15, 2021
- Venturis Therapeutics, Inc.
- Vance Gardner
- G01 - MEASURING TESTING
Information Patent Application
SYSTEMS AND METHODS FOR ANGIOGENIC TREATMENT IN WOUND HEALING
- Publication number 20200237873
- Publication date Jul 30, 2020
- Venturis Therapeutics, Inc.
- Vance Gardner
- G01 - MEASURING TESTING
Information Patent Application
THERAPEUTIC ANGIOGENESIS FOR TREATING ERECTILE CONDITIONS
- Publication number 20170340266
- Publication date Nov 30, 2017
- CardioVascular BioTherapeutics, Inc.
- Vance GARDNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC ANGIOGENESIS FOR WOUND HEALING
- Publication number 20170296625
- Publication date Oct 19, 2017
- CardioVascular BioTherapeutics, Inc.
- Vance GARDNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANGIOGENIC TREATMENT OF ISCHEMIC HEART DISEASE
- Publication number 20170296055
- Publication date Oct 19, 2017
- CardioVascular BioTherapeutics, Inc.
- Vance GARDNER
- G01 - MEASURING TESTING
Information Patent Application
MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISO...
- Publication number 20160263190
- Publication date Sep 15, 2016
- TREFOIL THERAPEUTICS, LLC
- David EVELETH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEMS AND METHODS FOR ANGIOGENIC TREATMENT IN WOUND HEALING
- Publication number 20150164994
- Publication date Jun 18, 2015
- CardioVascular BioTherapeutics, Inc.
- Vance Gardner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Angiogenesis for Treatment of the Spine and Other Tissues
- Publication number 20130230454
- Publication date Sep 5, 2013
- CardioVascular BioTherapeutics, Inc.
- Vance Gardner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic angiogenesis for treatment of the spine
- Publication number 20090076481
- Publication date Mar 19, 2009
- Cardio Vascular Biotherapeutics, Inc.
- THOMAS J. STEGMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitor of vascular endothelial cell growth factor
- Publication number 20070010442
- Publication date Jan 11, 2007
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Rat receptor tyrosine knase, kdr
- Publication number 20060057694
- Publication date Mar 16, 2006
- Kenneth A Thomas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
In vivo methods of determining activity of receptor-type kinase inh...
- Publication number 20040101478
- Publication date May 27, 2004
- Kenneth A Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitor of vascular endothelial cell growth factor
- Publication number 20030120038
- Publication date Jun 26, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human receptor tyrosine kinase, KDR
- Publication number 20030055239
- Publication date Mar 20, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DNA molecules encoding vascular endothelial cell growth factor II s...
- Publication number 20030045471
- Publication date Mar 6, 2003
- Merck & Co., Inc.
- Marvin L. Bayne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human receptor tyrosine kinase, KDR
- Publication number 20030032160
- Publication date Feb 13, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Gene therapy for stimulation of angiogenesis
- Publication number 20020065240
- Publication date May 30, 2002
- Merck & Co., Inc.
- Kenneth A. Thomas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

KENNETH A. THOMAS

Person

Patents Grantslast 30 patents

Systems and methods for angiogenic treatment in wound healing

Therapeutic angiogenesis for treatment of the spine and other tissues

Modified fibroblast growth factors for the treatment of ocular diso...

Angiogenic treatment of ischemic heart disease

Systems and methods for angiogenic treatment in wound healing

Therapeutic angiogenesis for treatment of the spine

Human receptor tyrosine kinase, KDR

Human receptor tyrosine kinase, KDR

Vascular endothelial cell growth factor C subunit

Angiogenesis inhibitors

Gene therapy for inhibition of angiogenesis

Human receptor tyrosine kinase, KDR

Angiogenesis inhibitors

Angiogenesis inhibitors

Human receptor tyrosine kinase, KDR

Vascular endothelial cell growth factor II

Vascular endothelial cell growth factor C subunit

Vascular endothelial cell growth factor C subunit

Inhibitor of vascular endothelial cell growth factor

Vascular endothelial cell growth factor II

DNA encoding a soluble VEGF inhibitor

Purification and characterization of a glioma-derived growth factor...

Cysteine-modified acidic fibroblast growth factor and methods of use

Brain derived and recombinant acidic fibroblast growth factor

DNA encoding glioma-derived growth factor having vascular endotheli...

Cysteine-modified acidic fibroblast growth factor

Cysteine-modified acidic fibroblast growth factor

Purification and characterization of a protein fibroblast growth fa...

Patents Applicationslast 30 patents

Systems and Methods for Angiogenic Treatment in Wound Healing

MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISO...

ANGIOGENIC TREATMENT OF ISCHEMIC HEART DISEASE

SYSTEMS AND METHODS FOR ANGIOGENIC TREATMENT IN WOUND HEALING

THERAPEUTIC ANGIOGENESIS FOR TREATING ERECTILE CONDITIONS

THERAPEUTIC ANGIOGENESIS FOR WOUND HEALING

ANGIOGENIC TREATMENT OF ISCHEMIC HEART DISEASE

MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISO...

SYSTEMS AND METHODS FOR ANGIOGENIC TREATMENT IN WOUND HEALING

Therapeutic Angiogenesis for Treatment of the Spine and Other Tissues

Therapeutic angiogenesis for treatment of the spine

Inhibitor of vascular endothelial cell growth factor

Rat receptor tyrosine knase, kdr

In vivo methods of determining activity of receptor-type kinase inh...

Inhibitor of vascular endothelial cell growth factor

Human receptor tyrosine kinase, KDR

DNA molecules encoding vascular endothelial cell growth factor II s...

Human receptor tyrosine kinase, KDR

Gene therapy for stimulation of angiogenesis